JonesResearch upgraded CervoMed (CRVO) to Buy from Hold with a $15 price target arguing that the company’s latest data from ...

Division A Region 3 Boys Basketball Tournament Championship game was held at the Minot State University (MSU) Dome on ...

Arista Networks Inc., which is the network vendor that has done the most effective job of tying its growth to AI, Wednesday announced new capabilities for its EOS Smart AI Suite designed to improve AI ...

Cognition Therapeutics, Inc. (Nasdaq: CGTX), a clinical stage company developing product candidates that treat neurodegenerative disorders, (the "Company” or "Cognition”), plans to release financial ...

CervoMed's Phase 2b study extension shows improved cognitive outcomes with neflamapimod, leading to an analyst upgrade and ...

The Embraer jets and Citation Jet 2+ will join Fox Aviation’s existing fleet, which includes a 24.1-year-old ...

Here is how Dolby Laboratories (DLB) and Netflix (NFLX) have performed compared to their sector so far this year.

Charles Schwab Investment Management Inc. raised its holdings in shares of Dolby Laboratories, Inc. (NYSE:DLB – Free Report) ...

The Division A, Region 3 Boys Basketball Tournament had two semifinal games on Tuesday, March 11, at the Minot State ...

Dolby collaborates with Cadillac, a GM company, to bring Dolby Atmos to electric vehicles, aiming to transform the in-car audio experience.

Roth MKM analyst Boobalan Pachaiyappan raised the firm’s price target on CervoMed (CRVO) to $15 from $7 and keeps a Buy rating on the shares.

CervoMed has announced positive results from the extension phase 2b RewinD-LB study of neflamapimod for dementia with Lewy ...